Laxatives Market Research Report Information Information by Drug Type (Hyperosmotic and Bulk-Forming), Route of Administration (Oral and Rectal), Indication (Chronic Constipation and Irritable Bowel Syndrome), End User (Hospitals & Clinics, Research Institutes and others) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2030

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL LAXATIVES MARKET, BY DRUG TYPE

6.1. Overview

6.2. Hyperosmotic

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Bulk-Forming

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Stool Softeners

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5. Lubricants

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6. Stimulants

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.7. Other

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION

7.1. Overview

7.2. Oral

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Rectal

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL LAXATIVES MARKET, BY INDICATION

8.1. Overview

8.2. Chronic Constipation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Irritable Bowel Syndrome

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

GLOBAL LAXATIVES MARKET, BY END USER

9.1. Overview

9.2. Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3. Research Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

10. GLOBAL LAXATIVES MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Laxatives Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of the Number of Developments in the Global Laxatives Market

11.7. Key developments and Growth Strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Mergers and Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix & Market Ratio

11.8.1. Sales & Operating Income 2020

11.8.2. Major Players R&D Expenditure 2020

11.9. Major Players Capital Market Ratio

12. COMPANY PROFILES

12.1. Bayer AG

12.1.1. Company Overview

12.1.2. Product Overview

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Boehringer Ingelheim Pharmaceuticals Inc.

12.2.1. Company Overview

12.2.2. Product Overview

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. Eskag Pharma Pvt. Ltd.

12.3.1. Company Overview

12.3.2. Product Overview

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. GlaxoSmithKline Plc

12.4.1. Company Overview

12.4.2. Product Overview

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Procter & Gamble Company

12.5.1. Company Overview

12.5.2. Product Overview

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Purdue Pharma L.P.

12.6.1. Company Overview

12.6.2. Product Overview

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Mallinckrodt Pharmaceuticals

12.7.1. Company Overview

12.7.2. Product Overview

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Abbott Laboratories

12.8.1. Company Overview

12.8.2. Product Overview

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Braintree

12.9.1. Company Overview

12.9.2. Product Overview

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Sucampo Pharmaceuticals

12.10.1. Company Overview

12.10.2. Product Overview

12.10.3. Financial Overview

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

12.11. Others

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL LAXATIVES MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL LAXATIVES MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 7 GLOBAL LAXATIVES MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 10 NORTH AMERICA: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 11 NORTH AMERICA: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 12 US: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 13 US: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 14 US: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 15 US: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 16 CANADA: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 17 CANADA: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 18 CANADA: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 19 CANADA: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 20 LATIN AMERICA: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 21 LATIN AMERICA: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 22 LATIN AMERICA: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 23 LATIN AMERICA: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 24 EUROPE: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 25 EUROPE: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 26 EUROPE: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 27 EUROPE: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 28 WESTERN EUROPE: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 29 WESTERN EUROPE: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 30 WESTERN EUROPE: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 31 WESTERN EUROPE: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 32 EASTERN EUROPE: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 33 EASTERN EUROPE: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 34 EASTERN EUROPE: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 35 EASTERN EUROPE: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: LAXATIVES MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: LAXATIVES MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: LAXATIVES MARKET, BY INDICATION, 2020-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: LAXATIVES MARKET, BY END USER, 2020-2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE OF THE GLOBAL LAXATIVES MARKET

FIGURE 3 MARKET DYNAMICS OF THE GLOBAL LAXATIVES MARKET

FIGURE 4 GLOBAL LAXATIVES MARKET SHARE, BY DRUG TYPE, 2020 (%)

FIGURE 5 GLOBAL LAXATIVES MARKET SHARE, BY ROUTE OF ADMINISTRATION, 2020 (%)

FIGURE 6 GLOBAL LAXATIVES MARKET SHARE, BY INDICATION, 2020 (%)

FIGURE 7 GLOBAL LAXATIVES MARKET SHARE, BY END USER, 2020 (%)

FIGURE 8 GLOBAL LAXATIVES MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: LAXATIVES MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: LAXATIVES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: LAXATIVES MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: LAXATIVES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: LAXATIVES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: LAXATIVES MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL LAXATIVES MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 BAYER AG.: KEY FINANCIALS

FIGURE 16 BAYER AG: SEGMENTAL REVENUE

FIGURE 17 BAYER AG: REGIONAL REVENUE

FIGURE 18 BOEHRINGER INGELHEIM PHARMACEUTICALS INC.: KEY FINANCIALS

FIGURE 19 BOEHRINGER INGELHEIM PHARMACEUTICALS INC.: SEGMENTAL REVENUE

FIGURE 20 BOEHRINGER INGELHEIM PHARMACEUTICALS INC.: REGIONAL REVENUE

FIGURE 21 ESKAG PHARMA PVT. LTD.: KEY FINANCIALS

FIGURE 22 ESKAG PHARMA PVT. LTD.: SEGMENTAL REVENUE

FIGURE 23 ESKAG PHARMA PVT. LTD.: REGIONAL REVENUE

FIGURE 24 GLAXOSMITHKLINE PLC: KEY FINANCIALS

FIGURE 25 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE

FIGURE 26 GLAXOSMITHKLINE PLC: REGIONAL REVENUE

FIGURE 27 PROCTER & GAMBLE COMPANY: KEY FINANCIALS

FIGURE 28 PROCTER & GAMBLE COMPANY: SEGMENTAL REVENUE

FIGURE 29 PROCTER & GAMBLE COMPANY: REGIONAL REVENUE

FIGURE 30 PURDUE PHARMA L.P.: KEY FINANCIALS

FIGURE 31 PURDUE PHARMA L.P.: SEGMENTAL REVENUE

FIGURE 32 PURDUE PHARMA L.P.: REGIONAL REVENUE

FIGURE 33 MALLINCKRODT PHARMACEUTICALS: KEY FINANCIALS

FIGURE 34 MALLINCKRODT PHARMACEUTICALS: SEGMENTAL REVENUE

FIGURE 35 MALLINCKRODT PHARMACEUTICALS: REGIONAL REVENUE

FIGURE 36 ABBOTT LABORATORIES: KEY FINANCIALS

FIGURE 37 ABBOTT LABORATORIES: SEGMENTAL REVENUE

FIGURE 38 ABBOTT LABORATORIES: REGIONAL REVENUE

FIGURE 39 BRAINTREE: KEY FINANCIALS

FIGURE 40 BRAINTREE: SEGMENTAL REVENUE

FIGURE 41 BRAINTREE: REGIONAL REVENUE

FIGURE 42 SUCAMPO PHARMACEUTICALS: KEY FINANCIALS

FIGURE 43 SUCAMPO PHARMACEUTICALS: SEGMENTAL REVENUE

FIGURE 44 SUCAMPO PHARMACEUTICALS: REGIONAL REVENUE